Premier Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Premier Biotech's estimated annual revenue is currently $13.5M per year.
- Premier Biotech's estimated revenue per employee is $155,000
Employee Data
- Premier Biotech has 87 Employees.
- Premier Biotech grew their employee count by 34% last year.
Premier Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.1M | 46 | 59% | N/A | N/A |
#2 | $7.4M | 48 | -35% | N/A | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $4.3M | 28 | 0% | N/A | N/A |
#5 | $3.6M | 19 | 6% | N/A | N/A |
#6 | $2M | 13 | 0% | N/A | N/A |
#7 | $4.3M | 28 | -3% | N/A | N/A |
#8 | $13.5M | 87 | 34% | N/A | N/A |
#9 | $14.7M | 95 | 0% | $20.5M | N/A |
#10 | $27.9M | 144 | 13% | $39.1M | N/A |
What Is Premier Biotech?
Premier Biotech Inc. is a leading manufacturer of rapid drug testing diagnostic devices. Our commitment is to deliver the most innovative and flexible testing menu in drugs of abuse. As an R&D focused organization, we have set an industry benchmark in bringing new tests and cutting-edge technology to market. Premier Biotech Labs, LLC is a CAP Forensic accredited laboratory. Both Premier Biotech Inc. and Premier Labs are located in Minnesota. Premier Labs provides customized laboratory services for toxicology testing in criminal justice/corrections, workplace, health & human services, and clinical medication monitoring. Premier Biotech is changing the game in drugs of abuse testing. We are pioneering new and innovative technology and services through comprehensive products and laboratory solutions. We no longer live in a world where the traditional 5 panel illicit drug tests are sufficient. As an R&D driven organization we have developed exclusive configurations that test for the newest trends in drug abuse including fentanyl, oxycodone, buprenorphine, tramadol, ketamine, K2 (spice) and more. Our product portfolio was developed to deliver exclusive configurations that test for the most relevant drugs of abuse. In the height of America's prescription drug epidemic and rise in synthetic opioids, our configurations include tests for these prescription pain pills and other relevant drugs of abuse. We understand the unique needs of our clients and the variations of their markets throughout the country including; Workplace Testing Criminal Justice Mental Health Pain Management Primary Care Treatment Providers Behavioral Healthcare Clinics Addiction Medicine Specialists Our Mission To develop innovative and customized drug testing products and solutions that deliver more accurate, reliable and faster results. Providing exceptional customer service and implement creative, flexible solutions to meet the needs of our customers.
keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
N/A
Total Funding
87
Number of Employees
$13.5M
Revenue (est)
34%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Premier Biotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Project Director | |
2 | VP Clinical Sales | |
3 | North East/Mid Atlantic Government Account Executive | |
4 | VP Sales | |
5 | VP Sales & Marketing | |
6 | Regulatory Affairs Manager | |
7 | Chief Financial Officer | |
8 | Director Product Operations and Development at Premier Biotech | |
9 | Analytics coordinator | |
10 | Customer Service Representative |
Premier Biotech News
... Collection and Diagnostic Market 2022 Trending Vendors OraSure Technologies, Quest Diagnostics, Abbott Laboratories, Premier Biotech.
... Oral Fluid Screening Devices Market 2022 Sales Revenue OraSure Technologies, Quest Diagnostics, Abbott Laboratories, Premier Biotech.
biotechnology The budget for the Department of Biotechnology, India's premier agency for life science development, is Rs. 2581 Crores,...
Other Companies in Minneapolis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23.5M | 87 | 12% | N/A |
#2 | $8.7M | 87 | -4% | N/A |
#3 | $21.8M | 87 | -7% | N/A |
#4 | $7.5M | 87 | 26% | N/A |
#5 | $7.5M | 88 | 11% | N/A |